Abstract
Live attenuated vaccines against mumps virus (MuV) have been traditionally produced by passaging the virus in the embryonated chicken eggs or primary chicken embryo fibroblasts (CEFs). Virus propagation on these cell substrates enables successful virus attenuation and retains it sufficiently antigenic to induce lasting protective immunity in humans. The aim of this study was to identify critical factors for MuV replication in primary CEFs grown on a small-scale level in order to explore possibilities for improvements in the virus replication and yield. The effect of differently prepared cells, culturing conditions, and infection conditions on virus yield was estimated by employing statistical design of experiments (DoE) methodology. Our results show that the preparation of primary CEFs and the way of their infection substantially impact virus yield and are critical for efficient MuV replication. These process parameters should be considered in further process optimization. We also demonstrate the applicability of DoE in optimization of virus replication as a crucial step in obtaining high virus yields.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Afzal MA, Dussupt V, Minor PD, Pipkin PA, Fleck R, Hockley DJ, Stacey GN (2005) Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations. J Virol Methods 126:149–156
Beck M, Welsz-Malecek R, Mesko-Prejac M, Radman V, Juzbasic M, Rajninger-Miholic M, Prislin-Musklic M, Dobrovsak-Sourek V, Smerdel S, Stainer DW (1989) Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. J Biol Stand 17:85–90
Carbone KM, Wolinsky JS (2001) Mumps virus. In: Knipe DM, Howley PM (eds) Fields-virology, 4th edn. Lippincott-Raven, Philadelphia, pp 1381–1400
Eriksson L, Johansson E, Kettaneh-Wold N, Wikström C, Wold S (2000) Design of experiments, principles and applications. Umetrics AB, Stockholm
Escoffier C, Gerlier D (1999) Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level. J Virol 73:5220–5224
Forcic D, Košutić-Gulija T, Šantak M, Jug R, Ivancic-Jelecki J, Markusic M, Mažuran M (2010) Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay. Vaccine 28:1887–1892
Freire MS, Mann GF, Marchevsky RS, Yamamura AM, Almeida LF, Jabor AV, Malachias JM, Coutinho ES, Galler R (2005) Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Vaccine 23:2501–2512
Glück R, Hoskins JM, Wegmann A, Just M, Germanier R (1986) Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Dev Biol Stand 65:29–35
Liang Y, Ma S, Liu L, Zhao H, Wang L, Jiang L, Xie Z, Dong C, Li Q (2010) Identification and development of a promising novel mumps vaccine candidate strain. Microbes Infect 12:1178–1187
Mandenius CF, Brundin A (2008) Bioprocess optimization using design-of-experiments methodology. Biotechnol Prog 24:1191–1203
Mayr A, Hochstein-Mintzel V, Stickl H (1975) Abstammung, eigenschaften und verwendung des attenuierten vaccinia-stammes MVA [Passage history, properties, and applicability of the attenuated vaccinia virus strain MVA]. Infection 3:6–14
Monath TP (1999) Yellow fever. In: Plotkin SA, Orenstein WA (eds) Vaccines, 3rd edn. Saunders, New York, pp 815–998
NIST/SEMATECH e-Handbook of Statistical Methods (2012). http://www.itl.nist.gov/div898/handbook/index.htm. Accessed 12 Apr 2012
Sassani A, Mirchamsy H, Shafyi A, Ahourai P, Razavi J, Gholami MR, Mohammadi A, Ezzi A, Rahmani M, Fateh G (1991) Development of a new live attenuated mumps virus vaccine in human diploid cells. Biologicals 19:203–211
Schaeffer WI (1990) Terminology associated with cell, tissue, and organ culture, molecular biology, and molecular genetics. Tissue culture association terminology committee. In Vitro Cell Dev Biol 26:97–101
Smorodinstev AA, Luzyanina TY, Mikutskaya BA (1965) Data on the efficiency of live mumps vaccine from chick embryo cell cultures. Acta Virol 9:240–247
Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vandeginste BG, Massart DL (2001) Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed Anal 24:723–753
World Health Organization (1994) Requirements for measles, mumps and rubella vaccines and combined vaccine (live). WHO Technical Report Series 840
World Health Organization (1998) Requirements for the use of animal cells as in vitro substrates for the production of biological. WHO Technical Report Series 878
World Health Organization (2007) Outbreak news: mumps virus vaccines. Wkly Epidemiol Rec 7:51–60
Acknowledgments
This work was supported by the Ministry of Science, Education and Sports of the Republic of Croatia, grant number 021-0212432-3123 (to M.Š.).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Markusic, M., Pavlović, N., Šantak, M. et al. Critical factors for the replication of mumps virus in primary chicken embryo fibroblasts defined by the use of design of experiments (DoE). Appl Microbiol Biotechnol 97, 1533–1541 (2013). https://doi.org/10.1007/s00253-012-4394-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-012-4394-4